11-18269312-C-T

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_199161.5(SAA1):​c.209C>T​(p.Ala70Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.547 in 148,460 control chromosomes in the GnomAD database, including 18,724 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.55 ( 18724 hom., cov: 28)
Exomes 𝑓: 0.55 ( 148135 hom. )
Failed GnomAD Quality Control

Consequence

SAA1
NM_199161.5 missense

Scores

17

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts P:1B:4

Conservation

PhyloP100: -0.932

Publications

36 publications found
Variant links:
Genes affected
SAA1 (HGNC:10513): (serum amyloid A1) This gene encodes a member of the serum amyloid A family of apolipoproteins. The encoded preproprotein is proteolytically processed to generate the mature protein. This protein is a major acute phase protein that is highly expressed in response to inflammation and tissue injury. This protein also plays an important role in HDL metabolism and cholesterol homeostasis. High levels of this protein are associated with chronic inflammatory diseases including atherosclerosis, rheumatoid arthritis, Alzheimer's disease and Crohn's disease. This protein may also be a potential biomarker for certain tumors. Finally, antimicrobial activity against S. aureus and E. coli resides in the N-terminal portion of the mature protein. Alternate splicing results in multiple transcript variants that encode the same protein. A pseudogene of this gene is found on chromosome 11. [provided by RefSeq, Jul 2020]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0011088252).
BP6
Variant 11-18269312-C-T is Benign according to our data. Variant chr11-18269312-C-T is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 18108.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.592 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
SAA1NM_199161.5 linkc.209C>T p.Ala70Val missense_variant Exon 3 of 4 ENST00000356524.9 NP_954630.2 P0DJI8
SAA1NM_000331.6 linkc.209C>T p.Ala70Val missense_variant Exon 3 of 4 NP_000322.3 P0DJI8
SAA1NM_001178006.3 linkc.209C>T p.Ala70Val missense_variant Exon 4 of 5 NP_001171477.2 P0DJI8

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
SAA1ENST00000356524.9 linkc.209C>T p.Ala70Val missense_variant Exon 3 of 4 1 NM_199161.5 ENSP00000348918.4 P0DJI8

Frequencies

GnomAD3 genomes
AF:
0.547
AC:
81134
AN:
148342
Hom.:
18715
Cov.:
28
show subpopulations
Gnomad AFR
AF:
0.532
Gnomad AMI
AF:
0.457
Gnomad AMR
AF:
0.502
Gnomad ASJ
AF:
0.408
Gnomad EAS
AF:
0.276
Gnomad SAS
AF:
0.451
Gnomad FIN
AF:
0.593
Gnomad MID
AF:
0.361
Gnomad NFE
AF:
0.597
Gnomad OTH
AF:
0.510
GnomAD2 exomes
AF:
0.479
AC:
73276
AN:
152964
AF XY:
0.479
show subpopulations
Gnomad AFR exome
AF:
0.499
Gnomad AMR exome
AF:
0.418
Gnomad ASJ exome
AF:
0.366
Gnomad EAS exome
AF:
0.250
Gnomad FIN exome
AF:
0.552
Gnomad NFE exome
AF:
0.543
Gnomad OTH exome
AF:
0.489
GnomAD4 exome
Data not reliable, filtered out with message: AS_VQSR;InbreedingCoeff
AF:
0.552
AC:
741180
AN:
1343586
Hom.:
148135
Cov.:
42
AF XY:
0.547
AC XY:
360796
AN XY:
659288
show subpopulations
African (AFR)
AF:
0.501
AC:
14629
AN:
29218
American (AMR)
AF:
0.445
AC:
12585
AN:
28292
Ashkenazi Jewish (ASJ)
AF:
0.383
AC:
8199
AN:
21404
East Asian (EAS)
AF:
0.266
AC:
9950
AN:
37428
South Asian (SAS)
AF:
0.432
AC:
30695
AN:
71050
European-Finnish (FIN)
AF:
0.584
AC:
28553
AN:
48930
Middle Eastern (MID)
AF:
0.348
AC:
1853
AN:
5320
European-Non Finnish (NFE)
AF:
0.579
AC:
605706
AN:
1046342
Other (OTH)
AF:
0.522
AC:
29010
AN:
55602
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.540
Heterozygous variant carriers
0
12038
24075
36113
48150
60188
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
19202
38404
57606
76808
96010
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.547
AC:
81183
AN:
148460
Hom.:
18724
Cov.:
28
AF XY:
0.540
AC XY:
39240
AN XY:
72622
show subpopulations
African (AFR)
AF:
0.532
AC:
21639
AN:
40682
American (AMR)
AF:
0.502
AC:
7504
AN:
14946
Ashkenazi Jewish (ASJ)
AF:
0.408
AC:
1392
AN:
3410
East Asian (EAS)
AF:
0.277
AC:
1414
AN:
5110
South Asian (SAS)
AF:
0.453
AC:
2143
AN:
4734
European-Finnish (FIN)
AF:
0.593
AC:
6166
AN:
10400
Middle Eastern (MID)
AF:
0.361
AC:
104
AN:
288
European-Non Finnish (NFE)
AF:
0.597
AC:
39372
AN:
65936
Other (OTH)
AF:
0.505
AC:
1041
AN:
2062
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.562
Heterozygous variant carriers
0
1543
3087
4630
6174
7717
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
738
1476
2214
2952
3690
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.535
Hom.:
3270
ExAC
AF:
0.487
AC:
57822

ClinVar

Significance: Benign/Likely benign
Submissions summary: Pathogenic:1Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
Sep 30, 2018
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Apr 30, 2020
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is associated with the following publications: (PMID: 23437051) -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

SERUM AMYLOID A VARIANT Pathogenic:1
Jun 01, 1995
OMIM
Significance:Pathogenic
Review Status:no assertion criteria provided
Collection Method:literature only

- -

SAA1-related disorder Benign:1
Apr 17, 2023
Department of Pathology and Laboratory Medicine, Sinai Health System
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:research

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.065
BayesDel_addAF
Benign
-0.80
T
BayesDel_noAF
Benign
-0.78
CADD
Benign
0.29
DANN
Benign
0.83
DEOGEN2
Benign
0.011
T;T;.;T
Eigen
Benign
-1.2
Eigen_PC
Benign
-1.2
FATHMM_MKL
Benign
0.020
N
LIST_S2
Benign
0.35
.;.;T;T
MetaRNN
Benign
0.0011
T;T;T;T
MetaSVM
Benign
-1.0
T
PhyloP100
-0.93
PrimateAI
Benign
0.31
T
PROVEAN
Benign
-1.1
N;N;.;N
REVEL
Benign
0.011
Sift
Benign
0.74
T;T;.;T
Sift4G
Benign
1.0
T;T;.;T
Vest4
0.013
MPC
1.7
ClinPred
0.0042
T
GERP RS
-0.058
gMVP
0.30
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.070
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1136743; hg19: chr11-18290859; COSMIC: COSV62945873; COSMIC: COSV62945873; API